|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Freitas AC, Gomes Leitão Mda C and
Coimbra EC: Prospects of molecularly-targeted therapies for
cervical cancer treatment. Curr Drug Targets. 16:77–91. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Q, Huang H, Gong Z, Xiong W, Zeng Z
and Li G: Advances in regulation of gene expression mediated by
lncRNAs. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 39:91–95. 2014.(In
Chinese). PubMed/NCBI
|
|
5
|
Liu W, Ma R and Yuan Y:
Post-transcriptional regulation of genes related to biological
behaviors of gastric cancer by long noncoding RNAs and MicroRNAs. J
Cancer. 8:4141–4154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Huang J, Liu T, He S, Shang C, Guo
L, Du Q and Yao S: Overexpression of long non-coding RNA
RP11-396F22.1 correlates poor prognosis of patients with
early-stage cervical cancer. Am J Transl Res. 10:684–695.
2018.PubMed/NCBI
|
|
7
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: lncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Cao X and Chen F: WITHDRAWN:
lncRNA-HOTAIR activates tumor cell proliferation and migration by
suppressing MiR-326 in cervical cancer. Oncol Res. Aug
31–2017.(Epub ahead of print). View Article : Google Scholar :
|
|
9
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783.
2014.PubMed/NCBI
|
|
10
|
Zhu FY, Chen MX, Ye NH, Shi L, Ma KL, Yang
JF, Cao YY, Zhang Y, Yoshida T, Fernie AR, et al: Proteogenomic
analysis reveals alternative splicing and translation as part of
the abscisic acid response in Arabidopsis seedlings. Plant J.
91:518–533. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang R, Jin H and Lou F: The long
non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain
glioma growth through HMGB1/RAGE pathway. J Cell Biochem.
119:3007–3016. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou Q, Zhou E, Xu F, Zhang D, Yi W and Yao
J: A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer
cell invasion and migration. J Cell Biochem. 119:2189–2199. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia L, Wu L, Bao J, Li Q, Chen X, Xia H
and Xia R: Circular RNA circ-CBFB promotes proliferation and
inhibits apoptosis in chronic lymphocytic leukemia through
regulating miR-607/FZD3/Wnt/β-catenin pathway. Biochem Biophys Res
Commun. 503:385–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du X, Lin LI, Zhang L and Jiang J:
microRNA-195 inhibits the proliferation, migration and invasion of
cervical cancer cells via the inhibition of CCND2 and MYB
expression. Oncol Lett. 10:2639–2643. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao XL, Zhao ZH, Xu WC, Hou JQ and Du XY:
Increased expression of SPRY4-IT1 predicts poor prognosis and
promotes tumor growth and metastasis in bladder cancer. Int J Clin
Exp Pathol. 8:1954–1960. 2015.PubMed/NCBI
|
|
17
|
Li X, Wang X, Mao L, Zhao S and Wei H:
lncRNA TP73-AS1 predicts poor prognosis and promotes cell
proliferation in ovarian cancer via cell cycle and apoptosis
regulation. Mol Med Rep. 18:516–522. 2018.PubMed/NCBI
|
|
18
|
Fan X, Chen W, Fu Z, Zeng L, Yin Y and
Yuan H: MicroRNAs, a subpopulation of regulators, are involved in
breast cancer progression through regulating breast cancer stem
cells. Oncol Lett. 14:5069–5076. 2017.PubMed/NCBI
|
|
19
|
González-Quintana V, Palma-Berré L,
Campos-Parra AD, López-Urrutia E, Peralta-Zaragoza O, Vazquez-Romo
R and Pérez-Plasencia C: MicroRNAs are involved in cervical cancer
development, progression, clinical outcome and improvement
treatment response (Review). Oncol Rep. 35:3–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Z, Yang H, Zhao M, Wang Y, Deng G and
Chen R: MicroRNA-92a promotes cell proliferation in cervical cancer
via inhibiting p21 expression and promoting cell cycle progression.
Oncol Res. 25:137–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Z, Wang J, Li J, Wang X and Song W:
MicroRNA-150 promotes cell proliferation, migration, and invasion
of cervical cancer through targeting PDCD4. Biomed Pharmacother.
97:511–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Wang J, Wang X, Song W, Shi Y and
Zhang L: MicroRNA-21 promotes proliferation, migration, and
invasion of cervical cancer through targeting TIMP3. Arch Gynecol
Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang YK, Xi WY, Xi RX, Li JY, Li Q and Gao
YE: MicroRNA-494 promotes cervical cancer proliferation through the
regulation of PTEN. Oncol Rep. 33:2393–2401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fang H, Shuang D, Yi Z, Sheng H and Liu Y:
Up-regulated microRNA-155 expression is associated with poor
prognosis in cervical cancer patients. Biomed Pharmacother.
83:64–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin YF, Li LH, Lin CH, Tsou MH, Chuang MT,
Wu KM, Liao TL, Li JC, Wang WJ, Tomita A, et al: Selective
retention of an inactive allele of the DKK2 tumor suppressor gene
in hepatocellular carcinoma. PLoS Genet. 12:e10060512016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang N, Wei H, Yin D, Lu Y, Zhang Y, Zhang
Q, Ma X and Zhang S: MicroRNA-195 inhibits proliferation of
cervical cancer cells by targeting cyclin D1a. Tumour Biol.
37:4711–4720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi C and Zhang Z: MicroRNA-362 is
downregulated in cervical cancer and inhibits cell proliferation,
migration and invasion by directly targeting SIX1. Oncol Rep.
37:501–509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang Z, Song Q, Zeng R, Li J, Li J, Lin
X, Chen X, Zhang J and Zheng Y: MicroRNA-218 inhibits EMT,
migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical
cancer. Oncotarget. 7:45622–45636. 2016.PubMed/NCBI
|
|
29
|
Chen CL, Wang Y, Pan QZ, Tang Y, Wang QJ,
Pan K, Huang LX, He J, Zhao JJ, Jiang SS, et al:
Bromodomain-containing protein 7 (BRD7) as a potential tumor
suppressor in hepatocellular carcinoma. Oncotarget. 7:16248–16261.
2016.PubMed/NCBI
|
|
30
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y
and Mu N: MicoRNA-425-5p is a potential prognostic biomarker for
cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Song KL, Chang H and Chen L:
Decreased expression of microRNA-126 is associated with poor
prognosis in patients with cervical cancer. Diagn Pathol.
9:2202014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deshpande A, Sicinski P and Hinds PW:
Cyclins and cdks in development and cancer: A perspective.
Oncogene. 24:2909–2915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ely S, Di Liberto M, Niesvizky R, Baughn
LB, Cho HJ, Hatada EN, Knowles DM, Lane J and Chenkiang S: Mutually
exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent
kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and
promotes cell cycle dysregulation in multiple myeloma. Cancer Res.
65:11345–11353. 2005. View Article : Google Scholar : PubMed/NCBI
|
